BDPT (BioAdaptives) Cyclically Adjusted FCF per Share: $-0.86 (As of Mar. 2026)


What is BioAdaptives Cyclically Adjusted FCF per Share?

BioAdaptives BDPT -28.50% Cyclically Adjusted FCF per Share is $-0.86 as of Mar. 2026. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BioAdaptives's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.007. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.86 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-04), BioAdaptives's current stock price is $0.00143. BioAdaptives's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-0.86. BioAdaptives's Cyclically Adjusted Price-to-FCF of today is .


BioAdaptives  (OTCPK:BDPT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BioAdaptives Cyclically Adjusted FCF per Share Related Terms


BioAdaptives Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for BioAdaptives's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAdaptives Cyclically Adjusted FCF per Share Chart

BioAdaptives Annual Data
Trend Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.88 -0.82

BioAdaptives Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -0.87 -0.86 -0.82 -0.86

BDPT vs NBND, BSFC, MEHA: Cyclically Adjusted FCF per Share Comparison

For the Packaged Foods subindustry, BioAdaptives's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioAdaptives Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Cyclically Adjusted Price-to-FCF falls into.



BioAdaptives Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioAdaptives's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.007/330.2130*330.2130
=-0.007

Current CPI (Mar. 2026) = 330.2130.

BioAdaptives Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.512 234.812 -0.720
201503 0.000 236.119 0.000
201506 -0.012 238.638 -0.017
201509 0.000 237.945 0.000
201512 0.000 236.525 0.000
201603 -0.022 238.132 -0.031
201606 0.000 241.018 0.000
201609 0.126 241.428 0.172
201806 0.000 251.989 0.000
201809 -1.364 252.439 -1.784
201812 -0.697 251.233 -0.916
201903 -0.311 254.202 -0.404
201906 -0.097 256.143 -0.125
201909 -0.256 256.759 -0.329
201912 -0.603 256.974 -0.775
202003 -0.333 258.115 -0.426
202006 -0.152 257.797 -0.195
202009 -0.245 260.280 -0.311
202012 -0.072 260.474 -0.091
202103 -0.319 264.877 -0.398
202106 -0.136 271.696 -0.165
202109 -0.147 274.310 -0.177
202112 -0.132 278.802 -0.156
202203 -0.170 287.504 -0.195
202206 -0.171 296.311 -0.191
202209 -0.104 296.808 -0.116
202212 -0.017 296.797 -0.019
202303 -0.011 301.836 -0.012
202306 -0.019 305.109 -0.021
202309 -0.012 307.789 -0.013
202312 -0.015 306.746 -0.016
202403 -0.005 312.332 -0.005
202406 -0.009 314.175 -0.009
202409 -0.007 315.301 -0.007
202412 -0.010 315.605 -0.010
202503 -0.011 319.799 -0.011
202506 -0.012 322.561 -0.012
202509 -0.015 324.800 -0.015
202512 -0.013 324.054 -0.013
202603 -0.007 330.213 -0.007

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.86 mean?
BioAdaptives (BDPT) has a Cyclically Adjusted FCF per Share of $-0.86 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioAdaptives and its competitors.
Is BioAdaptives' Cyclically Adjusted FCF per Share too high?
BioAdaptives' current Cyclically Adjusted FCF per Share is $-0.86.
How does BioAdaptives' Cyclically Adjusted FCF per Share compare to NBND and BSFC?
BioAdaptives' Cyclically Adjusted FCF per Share of $-0.86 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioAdaptives and its competitors. BioAdaptives's current Cyclically Adjusted FCF per Share is $-0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current Cyclically Adjusted FCF per Share of $-0.86. The current Cyclically Adjusted FCF per Share is $-0.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For BioAdaptives (BDPT), the current Cyclically Adjusted FCF per Share is $-0.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioAdaptives Business Description

Address 2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.